Big biotech shareholders could earn billions in takeovers

July 18 - A Reuters analysis finds the largest shareholders of biotechs bought into the companies at such low costs, they'll likely be willing sellers in a takeover bid and could make billions in profits.

rad ballet teachers online classes teachers graduate classes for teachers